Transcription-factor mutations and disease

New England Journal of Medicine

Volumn 334, Issue 1, 1996, Pages 28-33

  Latchman, David S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE; TRANSCRIPTION FACTOR; STEROID RECEPTOR; THYROID HORMONE RECEPTOR;

DISEASE CLASSIFICATION; DNA BINDING; DNA TRANSCRIPTION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; HORMONE RESPONSE; HUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; REVIEW; SURVIVAL RATE; CHILD; DEVELOPMENTAL DISORDER; GENE THERAPY; GENETIC TRANSCRIPTION; GENETICS; MUTATION; NEOPLASM;

CHILD; DEVELOPMENTAL DISABILITIES; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; MUTATION; NEOPLASMS; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0030568155     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/nejm199601043340108     Document Type: Review

References (43)

1. Latchman DS. Gene regulation: a eukaryouc perspective. 2nd ed London: Chapman & Hall, 1995.
2. Idem. Eukaryotic transcription factors. London: Academic Press, 1991.
3. Papavassiliou AG Transcription factors N Engl J Med 1995,332.45-7.
4. Verrijzer CP, Van der Vliet PC POU domain transcription factors. Biochim Biophys Acta 1993;1173:1-21.
5. Andersen B, Rosenfeld MG. Pit-1 determines cell types during development of the anterior pituitary gland: a model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 1994;269: 29335-8
6. Parker MG. Steroid and related receptors. Curr Opin Cell Biol 1993,5:499-504.
7. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency Science 1992;257 1115-8.
8. Pfaffle RW, DiMattia GE, Parks JS, et al Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992;257 1118-21.
9. de Kok YJ, van der Maarei SM, Bitner-Glindzicz M, et al. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995,267.685-8.
10. Hill RE, Hanson IM. Molecular genetics of the Pax gene family. Curr Opin Cell Biol 1992;4:967-72
11. Tassabehji M, Read AP, Newton VE, et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992;355:635-6.
12. Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995,9 358-63.
13. Ton CCT, Hirvonen H, Miwa H, et al. Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell 1991;67:1059-74.
14. Glaser T, Walton DS, Maas RL Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene Nat Genet 1992,2: 232-9.
15. Hanson IM, Fletcher JM, Jordan T, et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly Nat Genet 1994;6:168-73.
16. Hughes MR, O'Malley BW. Genetic defects of receptors involved in disease. In: Parker MG, ed. Nuclear homone receptors: molecular mechanisms, cellular functions, clinical abnormalities. London: Academic Press, 1991:321-53.
17. Baniahmad A, Tsai SY, O'Malley BW, Tsai MJ Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses. Proc Natl Acad Sci USA 1992;89: 10633-7.
18. Baniahmad A, Kohne AC, Renkawitz R. A transferable silencing domain is present in the thyroid hormone receptor in the v-erbA oncogene product and in the retinoic acid receptor EMBO J 1992;11 1015-23.
19. Zanaria E, Muscatelli F, Bardoni B, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994,372:635-41.
20. Bishop JM. The molecular genetics of cancer. Science 1987;235:305-11
21. Bourne HR, Varmus HE, eds Oncogenes and cell proliferation. Curr Opin Genet Dev 1992,2:1-57
22. Forrest D, Curran T. Crossed signals: oncogenic transcription factors Curr Opin Genet Dev 1992;2:19-27.
23. Rabbitts TH Chromosomal translocations in human cancer. Nature 1994, 372 143-9.
24. Spencer CA, Groudine M Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 1991;56:1-48.
25. Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene HOXI1, by the t(10;14) in T cell leukemia. Science 1991,253:79-82.
26. Sawyers CL, Denny CT. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about Cell 1994;77.171-3
27. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM A novel macromolecular structure is a target of the promyelocyte-retmoic acid receptor oncoprotein Cell 1994;76:333-43
28. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides Nature 1994,372:333-5.
29. Choo Y, Klug A Toward a code for the interaction of zinc fingers with DNA: selection of randomized fingers displayed on phage Proc Natl Acad Sci U S A 1994;91 11163-7. [Erratum. Proc Natl Acad Sci U S A 1995,92:646.]
30. Choo Y, Sanchez-Garcia I, Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 1994;372.642-5
31. Fredericks WJ, Gahli N, Mukhopadhyay S, et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcnptional activator than PAX3 Mol Cell Biol 1995, 15.1522-35
32. Knudson AG Antioncogenes and human cancer Proc Natl Acad Sci U S A 1993;90:10914-21.
33. Weinberg R. Tumor suppressor genes. Neuron 1993;11:191-6
34. Weinberg RA. The retinoblastoma protein and cell cycle control Cell 1995, 81:323-30
35. Hastie ND. Wilms' tumour gene and function. Curr Opin Genet Dev 1993, 3 408-13.
36. Berns A Cancer genetics: is p53 the only real tumor suppressor gene? Curr Biol 1994;4:137-9
37. Lane DP. p53, Guardian of the genome Nature 1992;358:15-6
38. Wagner S, Green MR. Retinoblastoma a transcriptional tryst Nature 1991, 352 189-90
39. Marx J. How p53 suppresses cell growth. Science 1993;262 1644-5
40. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 1995;80:293-9.
41. Friend S p53: A glimpse at the puppet behind the shadow play. Science 1994;265:334-5
42. Oliner JD, Pietenpol JA, Thiagahngam S, Gyuris J, Kinzler KW, Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature 1993;362:857-60.
43. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 1991,66.807-15.